AMONGStock Purchase Agreement • August 6th, 1999 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • New York
LEASE AGREEMENT THIS LEASE AGREEMENT, made on June 24, 2005, by and between HEMAGEN PROPERTIES, LLC, a Maryland limited liability company (hereinafter called "Landlord"), and HEMAGEN DIAGNOSTICS, INC., a Delaware corporation (hereinafter called...Lease Agreement • August 15th, 2005 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Maryland
SETTLEMENT AGREEMENT Agreement entered into as of September 30, 1999 among Hemagen Diagnostics, Inc., the following individual directors of Hemagen: Dr. Carl Franzblau, Dr. Ricardo de Oliveira, Dr. Alan S. Cohen, Lawrence Gilbert, Charles W. Smith and...Settlement Agreement • October 7th, 1999 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Delaware
Exhibit 10.30 SECOND AMENDMENT TO LEASE Hemagen Diagnostics, Inc., a Delaware corporation (hereinafter referred to as "Tenant"), entered into a Lease (hereinafter referred to as the "Lease") with the then owner of the 9033 Red Branch Road building in...Hemagen Diagnostics Inc • December 29th, 2000 • In vitro & in vivo diagnostic substances
WARRANT AGREEMENT HEMAGEN DIAGNOSTICS, INC., a Delaware corporation (the "Company"), and CONTINENTAL STOCK TRANSFER NJ, 2 Broadway, New York, New York ("Warrant Agent"), agree as follows: 1. Purpose. The Company proposes to issue 2,586,800 redeemable...Warrant Agreement • June 30th, 2000 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • New York
ARTICLE I DEFINITIONSLoan and Security Agreement • December 27th, 2002 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Maryland
AGREEMENT BY AND BETWEENAgreement • December 29th, 1997 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Massachusetts
Exhibit 4.3 FIRST AMENDMENT TO RIGHTS AGREEMENT -----------------------------------Rights Agreement • December 29th, 2000 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.42 DIRECTORS RULE 10(b)5-1Hemagen Diagnostics Inc • December 24th, 2003 • In vitro & in vivo diagnostic substances
August 23, 1996 Cellular Products, Inc. 872 Main Street Buffalo, NY 14202 Hemagen Diagnostics, Inc. or its nominee, ("Hemagen") hereby offers to purchase all of the assets of Cellular Products, Inc. ("CPI"), including without limitation all real...Hemagen Diagnostics Inc • November 14th, 1996 • In vitro & in vivo diagnostic substances
BETWEENTrust Agreement • December 27th, 2004 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Maryland
EXHBIT 2.01Asset Purchase Agreement • September 15th, 1998 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Delaware
EMPLOYEE AGREEMENT ------------------ To: RICARDO DE OLIVEIRA 40 Bear Hill Road Waltham, MA 02451 Effective May 18, 1999, The undersigned, Hemagen Diagnostics, Inc., a Delaware corporation (the "Company"), hereby agrees with you as follows: 1....Employee Agreement • August 16th, 1999 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Massachusetts
SECOND MODIFICATION AND AMENDMENT AGREEMENT THIS SECOND MODIFICATION AND AMENDMENT AGREEMENT (the "Agreement") is made this 24th day of June, 2005, by and between BAY NATIONAL BANK, a national banking association (the "Bank"), HEMAGEN DIAGNOSTICS,...Second Modification and Amendment Agreement • August 16th, 2005 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Maryland
EXHIBIT 10.34 CONDITIONAL LEASE TERMINATION AGREEMENT This Conditional Lease Termination Agreement is made and entered into this 30th day of March, 2001 by and between Philip and Rose M. Pagliazzo (collectively "Landlord") and Hemagen Diagnostics,...Conditional Lease Termination Agreement • December 21st, 2001 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Delaware
1 Exhibit 10.31 CONSULTING AGREEMENTConsulting Agreement • December 29th, 2000 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Ohio
EXHIBIT 10.50 QUOTA PURCHASE AND SALE AGREEMENT AND NON-COMPETITION AGREEMENTQuota Purchase and Sale Agreement and Non-Competition Agreement • December 27th, 2004 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances
ContractAsset Purchase Agreement • October 12th, 2007 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Delaware
STOCKHOLDER RIGHTS AGREEMENT Dated as of April 29, 2010 BY AND BETWEEN HEMAGEN DIAGNOSTICS, INC. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY as RIGHTS AGENTStockholder Rights Agreement • May 5th, 2010 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Delaware
STOCKHOLDER RIGHTS AGREEMENT, dated as of April 29, 2010 (this "Agreement"), by and between HEMAGEN DIAGNOSTICS, INC., a Delaware corporation (the "Company"), and CONTINENTAL STOCK TRANSFER & TRUST COMPANY (the "Rights Agent").
SECOND AMENDMENT TO RIGHTS AGREEMENTRights Agreement • January 24th, 2003 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances
This SECOND AMENDMENT TO RIGHTS AGREEMENT is made as of December 12, 2002 by and between Hemagen Diagnostics, Inc. (the “Company”), a Delaware corporation, and Continental Stock Transfer & Trust Company (the “Rights Agent”), a New York corporation.
EXHIBIT 10.32 SECOND RESTRUCTURING AGREEMENT This Second Restructuring Agreement ("Agreement") is made and entered into this 9 day of November, 2000 (the "Second Restructuring Date"), by and between Hemagen Diagnostics, Inc., a Delaware corporation...Second Restructuring Agreement • December 21st, 2001 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Delaware
RecitalsConstruction Loan Agreement • August 15th, 2005 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Maryland
Exhibit 2.02Asset Purchase Agreement • September 15th, 1998 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances
THIRD AMENDMENT TO LEASELease • September 12th, 2007 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Maryland
Hemagen Diagnostics, Inc., a Delaware corporation (hereinafter referred to as “Tenant”), entered into a lease with the then-owner of the building and surrounding property located at 9033 Red Branch Road in Columbia, Maryland (the “Property”) for a space containing approximately 27,975 square feet of gross floor area and 27,400 square feet of rentable area (the “Premises”). Thereafter, on or about December 30, 1997, the then-owner of the Property, E. Fulton Brylawski, conveyed his interest in the Property to 9033 Red Branch Road, LLC, a Maryland limited liability company (hereinafter referred to as “Landlord”). The Landlord and Tenant have amended the original lease twice. The First Amendment extended the term until June 30, 2002. The Second Amendment was executed by Landlord on June 15, 2000, and extended the lease term until June 30, 2007 (the original lease as well as any Amendments thereto including the Third Amendment, as defined below, are herein collectively referred to as the “L
RECITALSDistributorship Agreement • December 27th, 1996 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Massachusetts
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 28th, 2010 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Delaware
THIS EXECUTIVE EMPLOYMENT AGREEMENT ("Agreement") is made effective as of May 27, 2010 (the “Effective Date”) between HEMAGEN DIAGNOSTICS, INC., a Delaware corporation (the "Company"), and WILLIAM P. HALES (the "Executive").
SEVENTH MODIFICATION AND AMENDMENT AGREEMENTSeventh Modification and Amendment Agreement • April 30th, 2009 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Maryland
THIS SEVENTH MODIFICATION AND AMENDMENT AGREEMENT (this “Agreement”) is made this 30th day of April, 2009, but is effective as of March 31, 2009, by and between BAY NATIONAL BANK, a national banking association (the “Bank”), HEMAGEN DIAGNOSTICS, INC., a Delaware corporation, and REAGENTS APPLICATIONS, INC., a Delaware corporation (collectively, the “Borrower”).
NINTH MODIFICATION AND AMENDMENT AGREEMENTNinth Modification and Amendment Agreement • February 9th, 2011 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Maryland
THIS NINTH MODIFICATION AND AMENDMENT AGREEMENT (this “Agreement”) is made effective this 7th day of February, 2011, by and between TIFUNDING LLC, a Delaware limited liability company and successor in interest to each of BAY BANK, FSB, a federal savings bank, and BAY NATIONAL BANK, a national banking association (the “Bank”), HEMAGEN DIAGNOSTICS, INC., a Delaware corporation (the “Borrower”).
BETWEENDistributor Agreement • December 27th, 1996 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • New York
INVENTORY PURCHASE AGREEMENTInventory Purchase Agreement • October 12th, 2007 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Delaware
THIS INVENTORY PURCHASE AGREEMENT (this “Agreement”) is entered into on October 8, 2007 between Reagents Applications, Inc., a Delaware corporation (“RAI”) located at 8225 Mercury Court, San Diego, CA 92121 and Cliniqa Corporation, a California corporation (“Cliniqa”) located at 774 Twin Oaks Valley Road, San Marcos, CA 92069.
May 18, 1999 The undersigned, Hemagen Diagnostics, Inc., a Delaware corporation (the "Company"), hereby agrees with you as follows: 1. Position and Responsibilities. ------------------------------ 1. 1.1 You shall serve as Chief Executive Officer and...Key Employee Agreement • August 16th, 1999 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Massachusetts
Exhibit 1 --------- RIGHTS AGREEMENT This Rights Agreement (this "Agreement"), dated as of January 27, 1999, is by and between Hemagen Diagnostics, Inc. (the "Company"), a Delaware corporation, and Continental Stock Transfer & Trust Company (the...Rights Agreement • February 10th, 1999 • Hemagen Diagnostics Inc • In vitro & in vivo diagnostic substances • Delaware
